Products
14200 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nike Constant Leverage with ISIN code: CH1470667838 | Nike | Constant Leverage | Short | ― | 44.367 | 5.49 | 0.040 | 5.53 | 1 | -0.72% | -16.06% | -11.31% | 5 Jun. 2026 | |
| Nike Constant Leverage with ISIN code: CH1119067994 | Nike | Constant Leverage | Short | ― | 44.367 | 1.14 | 0.010 | 1.15 | 1 | -0.87% | -16.18% | -3.39% | 12 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450970210 | Nokia | Constant Leverage | Long | ― | 10.898 | 1.7 | 0.050 | 1.75 | 1 | -2.86% | -43.14% | -89.93% | 3 Nov. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 10.898 | 21.12 | 0.650 | 21.77 | 1 | -2.99% | -42.97% | -90.19% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 10.898 | 6.42 | 0.090 | 6.51 | 1 | -1.38% | -16.84% | -58.74% | 6 May. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 124.632 | 18.81 | 0.170 | 18.98 | 1 | -0.90% | -10.04% | 4.67% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 124.632 | 6.24 | 0.110 | 6.35 | 1 | -1.73% | -20.10% | 2.97% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 124.632 | 13.63 | 0.160 | 13.79 | 1 | -1.16% | -15.02% | 4.77% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 124.632 | 1.69 | 0.030 | 1.72 | 1 | -1.74% | -25.22% | 0.00% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 124.632 | 20.67 | 0.450 | 21.12 | 1 | -2.13% | -30.31% | -4.35% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 124.632 | 0.069 | 0.003 | 0.072 | 1 | -4.17% | 6.15% | -23.33% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1470667580 | Novartis | Constant Leverage | Short | ― | 124.632 | 2.82 | 0.060 | 2.88 | 1 | -2.08% | 19.49% | -45.24% | 5 Jun. 2026 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 124.632 | 0.52 | 0.030 | 0.55 | 1 | -5.45% | 1.96% | -17.46% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1470667598 | Novartis | Constant Leverage | Short | ― | 124.632 | 4.63 | 0.080 | 4.71 | 1 | -1.70% | 13.20% | -29.10% | 5 Jun. 2026 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 324.116 | 1.71 | 0.030 | 1.74 | 1 | -1.72% | -2.84% | 56.88% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 324.116 | 1.26 | 0.030 | 1.29 | 1 | -2.33% | -2.33% | -46.38% | 13 Oct. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 210.926 | 130.48 | 0.690 | 131.17 | 1 | -0.53% | 26.83% | 4.72% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1217423008 | Nvidia | Constant Leverage | Long | ― | 210.926 | 6.49 | 0.060 | 6.55 | 1 | -0.92% | 37.79% | 0.46% | 4 Nov. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 210.926 | 1.38 | 0.030 | 1.41 | 1 | -2.13% | 24.32% | -0.72% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1290992705 | Nvidia | Constant Leverage | Long | ― | 210.926 | 0.05 | ― | ― | 1 | 0.00% | 35.14% | 0.00% | 5 Feb. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.